Skip to content

Injectable

Active Private limited companyfounded 2023active for 3 yearsArsène De Preststraat 1, 9950 LievegemKBO/BCE: BE 0803.246.706

Overview

Lifetime

2 annual accounts with figures on one time axis
peak €59,170 (2025)
€59,170▲ 22.5%
peak €43,705 (2025)
€43,705▲ 23.3%
peak €84,153 (2025)
€84,153▲ 108%
€19,600▲ 13.3%
Board1 name since 2023
1 directorTANT Sander
Documentsfilings and deeds
26-01-20265 days before the deadline
2025micro format
Gross margin from €48,300 to €59,170Equity from €40,448 to €84,153Cash from €43,059 to €82,143

Key points

from the 2025 annual accounts

Turnover

≈ €140,000 estimated

The micro format states no turnover.

Liquidity

5.35 was 3.32 in 2024

Short-term debts rose from €17,194 to €19,328.

Checked score

98
Excellent
Financially stronger than 85% of micro companies in computer programming and consultancy (NACE 62)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.1% across 25,932 companies (NACE 62, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.4%highest value 01-2025: 0.4%● unchanged vs 12-2024highest value 02-2025: < 0.1%▼ -0.4 percentage points vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

100+5equity 81.1% of total assets
95+7short-term debt 18.6% · cash 79.2%
100=return on assets 42.1%

Score breakdown

raises risk
Founded in 2023
lowers risk
Liquidity: current ratio 5.35, cash €82,143
Sector: Computer programming, consultancy and related activities (NACE 62)
Equity €84,153 (81.1% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 62, micro). It does better than 85% of them on solvency, 84% on liquidity, 82% on profitability and 90% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-06-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 39,278 companies had the same profile as Injectable has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of Injectable itself is lower: < 0.1% within 12 months. It rests on far more data about Injectable than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for Injectable. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €8,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 5.35 (3.32 in 2024), above the usual 1.5. Short-term debt is 18.6% and cash 79.2% of total assets. 18.9% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 5.35, cash €82,143
NBB · annual accounts
lowers risk · Sector: Computer programming, consultancy and related activities (NACE 62)
KBO
raises risk · Founded in 2023
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €84,153 (81.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 26-01-2026, 5 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
5 days early
2024
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 4 days before the deadline. In the sector (NACE 62), the median for financial year 2024 was 9 days before the deadline, and 33% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end10-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Board and ownership

TS
Director, since 27-06-2023
  • TANT Sander 100 sharesdeed of 29-06-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0803246706
Incorporation Founding capital of €5,000, 100 shares · Founder: TANT Sander · Appointment: TANT Sander (director) · published on 29-06-2023 · Gazette deed
First establishment Arsène De Preststraat 1, Lievegem
All 5 events

Comparable companies

same main activity, similar in size and age
Company
Injectable Lievegem €103,753 €59,170 81.1% -
Tom Van Den Bossche Merelbeke-Melle €107,139 €54,017 90.6% -
RidgIT Aalst €110,002 €58,849 88.7% -
BLUE LIGHT SOLUTION Aalst €123,190 €59,118 46.2% -
Brilliant Bits Ghent €117,448 €50,814 57.7% -
Innovise Consulting Beveren-Kruibeke-Zwijndrecht €115,767 €71,340 91.1% -
Endevr Deinze €120,972 €62,277 92.1% -

These companies have the same main activity as Injectable: computer programming (NACE 62100). They are comparable in size and age: total assets between €107,000 and €123,000, founded between 2022 and 2024.

Official details

Source: KBO
Status
Active since 27-06-2023Normal situation
Activity
Computer programmingNACE 62100and 3 others
Establishment unit
2.346.560.0589950 Lievegem, since 27-06-2023
Financial year end
30 June
Peppol
Reachable since 03-10-2025
Company details

Annual accounts to 30-06-2025

€59,170▲ 22.5%
€43,705▲ 23.3%
€84,153▲ 108%
€103,753▲ 79.7%
Filing
Filed on 26-01-2026, 5 days before the end of the filing period
Financials

Insights on Injectable

Injectable has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €84,153 and a net result of €43,705.

Its solvency ranks better than 76% of 21,208 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 26-01-2026, 5 days before the deadline
€59,170
▲ 22.5%
€56,632
▲ 20.2%
€43,705
▲ 23.3%
€84,082
▲ 111%
81.1%
▲ 11.1 percentage points
5.35
▲ 2.03

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €140,000. Estimated: probably between €110,000 and €180,000.

Balance sheet

balance sheet total €103,753 on 30-06-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

81.1%

Higher than 76% of 21,208 companies in 2025.

5.35

Higher than 77% of 20,571 companies in 2025.

42.1%

Higher than 80% of 20,746 companies in 2025.

Injectable Middle half of the sector 80% of the sector Micro accounts in computer programming and consultancy (NACE 62)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024
Balance sheet: assets
20/58 103,75357,749
21/28 342648
22/27 342648
24 342648
29/58 103,41057,101
40/41 18,86611,815
40 18,86111,815
41 4-
54/58 82,14343,059
490/1 2,4012,227
Balance sheet: equity and liabilities
10/49 103,75357,749
10/15 84,15340,448
10/11 5,0005,000
14 79,15335,448
17/49 19,60017,301
42/48 19,32817,194
44 200730
440/4 200730
45 18,34916,297
450/3 17,09915,097
454/9 1,2501,200
47/48 779167
492/3 272107
Income statement
9900 59,17048,300
630 3061,195
640/8 2,232-
9901 56,63247,105
75/76B 2192
75 2192
65/66B 1,5702,167
65 1,5702,167
9903 55,28044,940
67/77 11,5759,493
9904 43,70535,448
9905 43,70535,448
Appropriation of the result
9906 79,15335,448
14P 35,448-
Document PDFPDF

The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 26-01-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-06-2025 micro format 26-01-2026 2026-00013212 PDF
30-06-2024 micro format 29-01-2025 2025-00013973 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024
56,93848,300
44,01136,643
01,843
39,084-
84,08239,906
81.1%70.0%
5.353.32
0.230.43
51.9%87.6%
42.1%61.4%
36.2622.29

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item30-06-202530-06-2024
Tangible fixed assets-€917
Intangible fixed assets-€926
€306€1,195

Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)

Insights on Injectable

The operating result for 2025 is 20% higher than in 2024.

Debt's share of the balance-sheet total falls from 30.0% to 18.9%. Equity and debt are higher.

Board & ownership

Board

1 director, since incorporation
Director (not named in the articles)
since 27-06-2023 term without a fixed end
listed in the 2025 annual accounts, filed on 26-01-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
TANT Sander
Director (not named in the articles)
Board
Mandates as a list
  • TANT Sander
    • Director (not named in the articles), from 27-06-2023 to date

See the board, name and registered office on a given date →

Control

Founder
This company
Injectable
Equity €84,153
Profit €43,705 in 2025

Capital

Contribution
€5,000
Shares
100
Contribution per share
€50
Equity per share
€842 in 2025
Source
deed of 29-06-2023

Articles of association

deed of 29-06-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Saturday of December at 17:00
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Shareholders

At incorporation deed of 29-06-2023 ↗

Network & group

No group

Injectable has no parent and no holdings in its annual accounts. TANT Sander is the only director. Injectable shares no director with another company.

Timeline

Timeline

5 events since 2023

Deadline for the 2026 accounts: 31-01-2027

2026
Annual accounts 2025 filed PDFmicro format · 5 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0803246706
Annual accounts 2024 filed PDFmicro format · 2 days before the deadline
2023
IncorporationFounding capital of €5,000, 100 shares · Founder: TANT Sander · Appointment: TANT Sander (director) · published on 29-06-20235 points ▸
  • Founder, TANT Sander
  • Founding capital, €5,000, 100 shares
  • Registered office clause, Arsène De Preststraat 1, 9950 Lievegem
  • Board rule, 1
  • Director appointment, TANT Sander (director (not named in the articles))
  • The deed holds 7 more points.

Open the deed in the Belgian Official Gazette

First establishment Arsène De Preststraat 1, Lievegem

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 27 June 2023, Injectable was incorporated as a private limited company by one natural person, with a starting capital of €5,000.12 TANT Sander has served as director since 2023.3 The company has filed 2 sets of annual accounts, the latest for financial year 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 29-06-2023
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2025

Company details

Identity

Enterprise number
0803.246.706
VAT number
BE 0803.246.706
Peppol ID
0208:0803246706
Other Peppol ID
9925:BE0803246706
Legal form
Private limited company
Status
Active, normal situation
Founded
27-06-2023
Financial year
ends on 30 June
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Saturday of December at 17:00
deed of 29-06-2023 (in Dutch)
Peppol
Reachable since 03-10-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
Injectable in Dutch
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 29-06-2023 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 29-06-2023 (in Dutch)

Activities

NACEBEL 2025
62100 Computer programming main activity
Codes under NACEBEL 2008
62010 Computer programming, consultancy and related activities main activity
47410 Retail trade
63110 Computing infrastructure, data processing, hosting and other information service activities
63120 Computing infrastructure, data processing, hosting and other information service activities
PurposeThe purpose describes the activities the company may carry out under its articles.
“Het ontwikkelen,het programmeren en het commercialiseren van computersoftware in de meest ruime zin van het woord; Het uitvoeren van alle…”
21 activities
  1. Het ontwikkelen,het programmeren en het commercialiseren van computersoftware in de meest ruime zin van het woord.
  2. Het uitvoeren van alle computerconsultancy activiteiten.
  3. De verhuur en de operationele van kantoormachines in de meest ruime zin van het woord,met inbegrip van het verhuur van software.
  4. De aan-en verkoop van virtual reality,internet en toebehoren.
  5. Het beheren van alle computerfaciliteiten.
  6. Het geven van adviezen,onderwijs,opleidingen en workshops met betrekking tot de voornoemde activiteiten.
  7. Het uitgeven van computerspelletjes,software en allerlei andere informatica toepassingen.
  8. Het beheren van gegevens via de computer of het internet,webhosting en alle andere aanverwante activiteiten.
  9. Het verlenen van bijstand en advies aan de gebruikers over zowel de hardware als de software en hun configuratie ervan.
  10. Het uitoefenen van alle activiteiten met betrekking tot webportalen.
  11. De aan- en verkoop,de groot- en kleinhandel,de invoer en de uitvoer van kantoormachines en kantoorbenodigdheden,computers,randapparatuur,software,hardware en allerhande telecommunicatieapparatuur,in de ruimste zin van het woord.
  12. Het uitvoeren van alle managementactiviteiten,het leveren van diensten en adviezen aan vennootschappen,ondernemingen en verenigingen,het tussenkomen in het dagelijks bestuur van bedrijven,het verstrekken van adviezen en bijstand op het gebied van public relations,communicatie,bedrijfsbeheer,bedrijfsvoering,financieel beheer,consultancy,planning,organisatie,efficiëntie,toezicht administratie …enzovoort.
  13. Het vertegenwoordigen van bedrijven en ondernemingen op grond van het bezit van of de controle over het kapitaal…enzovoort.
  14. Het verwerven van participaties,in eender welke vorm,in alle bestaande of op te richten rechtspersonen en ondernemingen.
  15. Het coördineren,stimuleren en plannen van de ontwikkeling van rechtspersonen en ondernemingen.
  16. Het waarnemen van bestuurs- en andere opdrachten,mandaten en functies in andere vennootschappen en ondernemingen.
  17. Het aanleggen,het oordeelkundig uitbouwen en beheren van een onroerend vermogen. Alle verrichtingen met betrekking tot onroerende goederen en onroerende zakelijke rechten (vruchtgebruik,recht van opstal,erfpacht…enzovoort),zoals de huurfinanciering van onroerende goederen aan derden,het aankopen,verkopen,ruilen,bouwen,verbouwen,onderhouden,verhuren,huren,ter beschikking stellen,verkavelen,prospecteren en uitbaten van alle onroerende goederen,
  18. Het ontwerpen en opvolgen van projecten,de aan- en verkoop,huur en verhuur van roerende goederen betreffende de inrichting en uitrusting van onroerende goederen,alsmede alle handelingen die rechtstreeks of onrechtstreeks met dit voorwerp in verband staan en die van aard zijn de opbrengst van de onroerende goederen te bevorderen. Het zich borg stellen voor eht goede verloop van verbintenissen,door derde personen aangegaan,die het genot zouden hebben van voormelde roerende en onroerende goederen.
  19. De bemiddeling in en het beheer van onroerend goed voor rekening van derden zowel bij aankoop,verkoop en verhuring van alle onroerende goederen.
  20. Het aanleggen,het oordeelkundig uitbouwen en beheren van een roerend vermogen; alle verrichtingen met betrekking tot roerende goederen en rechten,van welke aard ook,zoals het verwerven door inschrijving of aankoop,het beheren van aandelen,aandelenopties,obligaties,kasbons,afgeleide producten of andere roerende waarden,van welke vorm ook,uitgegeven door Belgische of buitenlandse emittenten.
  21. Het toestaan van leningen en kredietopeningen aan rechtspersonen en ondernemingen of particulieren,in eender welke vorm; het zich borg stellen of aval verlenen,in de meest ruime zin; alle handelsoperaties en financiële operaties verrichten,behalve deze die wettelijk voorbehouden zijn aan depositobanken,houders van deposito’s op korte termijn,spaarkassen,hypotheekmaatschappijen en kapitalisatieondernemingen.
deed of 29-06-2023 (in Dutch)

Registered office and establishments

1 establishment
Establishment Since Unit number
Arsène De Preststraat 1 registered office 9950 Lievegem 27-06-2023 2.346.560.058

Buildings and parcels at the address

Ground area
398 m²
Buildings
87 m²
Buildings to scale, each on its own parcel
87 m², 0.0 m 87 m², 0.0 m

Location

registered office establishment The establishment unit on the map

Parcels

Cadastral parcelArea Buildings Height / floors
44072E1253/00F004398 m² 1 · 87 m² 0.0 m

Contact

E-mail info@injectable.be establishment in Lievegem